Why the study?
The 2020 ESC guidelines for atrial fibrillation introduced changes regarding anticoagulant therapy in patients developing acute cerebrovascular accidents, prompting a review of these statements for clinical practice.
This review highlights key updates from the 2020 ESC Guidelines on atrial fibrillation relevant to neurologists, particularly regarding anticoagulation timing after stroke.
Clinical practice guidelines for the diagnosis and management of atrial fibrillation (AF) are one of the most regularly updated documents by the European Society of Cardiology. The new version of clinical practice guidelines (2020) contains a number of changes regarding anticoagulant therapy in patients with AF who have developed acute cerebrovascular accidents. In this review, we discuss the statements of the updated document on the timing of the start/restart of anticoagulant therapy after ischemic stroke and intracranial hemorrhage in patients with AF, the choice of antithrombotic therapy in patients with cryptogenic stroke, as well as the need for the additional testing to clarify the origin of the embolism. We provide our original position on the possibility of applying these recommendations to the real clinical practice.
No takes yet. Share an insight, caveat, or question.
Yanishevskiy et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: